Insulin Secretion
11
1
1
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
18.2%
2 terminated out of 11 trials
77.8%
-8.7% vs benchmark
18%
2 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
The Glucose-Independent Effects of Exogenous Glucagon on Insulin Secretion and Cognitive Function in Healthy Subjects
Intermittent Fasting to Improve Insulin Secretion
Regulation of Insulin Secretion by the GLP-1 Receptor
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Effect of Spinal Cord Stimulation (SCS) on Insulin Secretion in Humans
Incretin Action in Physiology and Diabetes
Effect of Taking a Single Tablet of Iron on Insulin Secretion
Glucagon Regulation of Glucose Metabolism
Maternal GDM in Hispanic Youth: Risk for Obesity
Influence of Central Nervous Insulin Sensitivity on Insulin Secretion
Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics